CenterBook Partners’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
CenterBook Partners's ATEX Position: Q2 2026 in Review
CenterBook Partners reduced its Anterix (ATEX) stake by 95% in Q2 2026, selling an estimated $7.09M and leaving 6,877 shares worth $708K. The position accounts for 0.03% of the portfolio, ranked #439.
CenterBook Partners first reported a position in ATEX in Q4 2021 and has held it in 12 quarters since. The position peaked at $4.88M in Q1 2026. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- CenterBook Partners held 6,877 shares of Anterix worth $708K as of Q2 2026.
- CenterBook Partners sold 120,797 Anterix shares in Q2 2026, an estimated $7.09M.
- Anterix made up 0.03% of CenterBook Partners's portfolio in Q2 2026, its #439 holding.
- CenterBook Partners first reported a position in Anterix in Q4 2021 and has held it in 12 quarters since.
- CenterBook Partners's Anterix position peaked at $4.88M in Q1 2026.
- 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.